Skip to main content

Table 1 Characteristics of SEBAS study population by childhood, young adulthood, active professional and older-age SEP

From: Association between life-course socioeconomic position and inflammatory biomarkers in older age: a nationally representative cohort study in Taiwan

Variable

Childhood SEP

Young adulthood SEP

Active professional life

Older age SEP

n

Low

Med

High

pa

Low

Med

High

p

Low

Med

High

p

Low

Med

High

p

466

168

398

 

268

381

380

 

180

446

410

 

456

307

237

 

Social Demographic Variables

 Mean age, in year

66.7

66.7

63.1

<.001

71.1

64.1

62.5

<.001

71.8

64.8

62.9

<.001

65.7

65.1

63.7

0.03

  (SD)

(9.1)

(10.5)

(9.3)

 

(8.8)

(8.8)

(9.1)

 

(8.6)

(9.0)

(9.2)

 

(9.2)

(9.4)

(9.8)

 

 Women, %

47.0

50.9

44.0

<.001

67.1

43.5

33.6

<.001

74.3

46.0

32.8

<.001

42.3

53.9

43.2

<.01

 Low childhood SEP, %

    

75.3

53.0

19.4

<.001

76.4

56.7

21.4

<.001

55.0

47.1

31.5

<.001

 Low young adulthood SEP, %

42.7

23,9

8.1

<.001

    

100

18.8

0.7

<.001

33.1

23.6

14.0

<.001

 Low active professional SEP, %

29.4

15.0

5.3

<.001

68.0

0.0

0.0

<.001

    

21.3

16.1

10.0

<.001

 Low older age SEP, %

53.8

46.6

36.5

<.001

59.4

53.0

29.6

<.001

59.5

47.2

44.3

<.001

    

Physiological marker

 Hypertension: SBP > 140 mmHg or DBP > 90 mmHg or using anti-hypertensive medication, %

50.0

48.0

46.2

0.43

60.1

45.3

43.1

<.001

56.4

57.4

54.2

0.92

48.7

46.5

46.3

0.14

 High total cholesterol: > = 240 mg/dL or using anti-hyperlipidemia medication, %

17.1

24.2

2.1

0.30

17.2

18.4

21.1

0.56

18.2

17.0

22.4

0.28

18.7

18.5

21.7

0.08

 Low high-density lipoprotein (HDL) cholesterol: < 40 mg/dL, %

18.6

15.6

15.1

0.27

19.8

16.3

15.6

0.59

21.1

16.5

15.2

0.09

17.8

16.5

16.4

0.95

 C-reactive protein (CRP, mg/dL), Mean

0.17

0.18

0.15

0.20

0.18

0.19

0.14

<.001

0.17

0.19

0.14

<.001

0.17

0.16

0.14

0.01

  (SD)

(0.3)

(0.2)

(0.2)

 

(0.3)

(0.3)

(0.2)

 

(0.3)

(0.3)

(0.2)

 

(0.3)

(0.2)

(0.2)

 

 Interleukin-6 (IL-6, pg/mL), Mean

3.2

3.3

2.9

0.17

4.0

3.2

3.0

<.001

3.9

3.3

3.2

0.02

3.4

3.3

3.0

0.28

  (SD)

(3.5)

(3.5)

(3.1)

 

(3.4)

(3.0)

(2.8)

 

(3.5)

(2.8)

(3.1)

 

(3.2)

(2.9)

(2.8)

 

Behavioral Risk Factor

 Current smoker, %

20.6

16.6

18.5

0.49

13.5

23.1

19.3

<.01

8.5

23.0

20.0

<.01

22.8

16.0

16.8

0.05

 Frequent or daily drinking,%

7.0

8.0

3.8

<.001

4.2

8.7

4.5

<.001

4.3

7.6

4.8

<.001

7.9

4.5

3.8

<.01

 Less than five servings of vegetable and fruit per day, %

53.8

59.5

46.2

<.01

56.2

58.2

41.6

<.001

55.3

57.9

42.7

<.001

59.6

47.5

38.9

<.001

 Exercise less than 3 times per week, %

55.4

53.9

54.1

<.01

63.7

55.9

46.3

<.001

65.0

57.0

46.6

<.001

62.6

50.4

41.4

<.001

 Obesity(BMI > = 27)

26.4

27.6

23.3

0.09

27.6

28.4

20.6

0.03

25.9

28.7

21.2

0.05

25.0

26.6

24.0

0.17

Psychosocial Factor

 Depressive symptoms %

17.6

19.2

11.8

0.03

26.9

13.0

10.3

<.001

26.1

15.8

10.4

<.001

22.2

13.9

5.4

<.001

 Perceived Stress (average score 0–4), Mean

3.0

2.9

2.0

0.20

2.9

3.0

3.0

0.08

2.9

3.0

3.0

0.13

2.9

3.0

3.2

<.001

  (SD)

(0.6)

(0.7)

(0.6)

 

(0.7)

(0.6)

(0.6)

 

(0.7)

(0.6)

(0.6)

 

(0.7)

(0.7)

(0.5)

 
  1. a: p-value of ANOVA test for continuous variables and p-value of chi-square test for categorical variables